UT-15C SR (treprostinil diethanolamine) ( DrugBank: Treprostinil )

---

1 disease

ID	Disease name (Link within this page)	Number of trials
86	Pulmonary arterial hypertension	3

86. Pulmonary arterial hypertension

---

Clinical trials : 1,181 /  Drugs : 701 - (DrugBank : 126) / Drug target genes : 105 - Drug target pathways : 192

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01934582 (ClinicalTrials.gov)	August 2013	29/8/2013	A Pharmacokinetic Substudy of the TDE-PH-304 Protocol	A Pharmacokinetic Substudy of Subjects Transitioning From Twice Daily to Three Times Daily Dosing of UT-15C SR (Treprostinil Diethanolamine) in the TDE-PH-304 Protocol	Pulmonary Arterial Hypertension	Drug: UT-15C SR;Drug: treprostinil diethanolamine	United Therapeutics	NULL	Completed	12 Years	75 Years	All	13	Phase 3	United States
2	NCT01131845 (ClinicalTrials.gov)	May 2010	10/5/2010	The Effect of Renal Impairment on the Pharmacokinetics of Oral Treprostinil	An Evaluation of the Pharmacokinetics and Safety of a Single Dose of UT-15C SR (Treprostinil Diethanolamine) in Subjects With Renal Impairment.	Pulmonary Arterial Hypertension;Renal Dysfunction	Drug: UT-15C SR (treprostinil diethanolamine)	United Therapeutics	NULL	Completed	18 Years	79 Years	Both	16	Phase 1	United States
3	NCT00963027 (ClinicalTrials.gov)	September 2009	19/8/2009	Effect of Esomeprazole on the Pharmacokinetics of Oral Treprostinil	An Evaluation of Single Dose UT-15C SR (Treprostinil Diethanolamine) Pharmacokinetics Following Repeated Dosing With the Proton Pump Inhibitor Esomeprazole in Healthy Adult Volunteers	Hypertension, Pulmonary;Pulmonary Arterial Hypertension	Drug: Treprostinil diethanolamine;Drug: Esomeprazole	United Therapeutics	NULL	Completed	18 Years	55 Years	Both	30	Phase 1	United States